PharmGen Science Dirección
Dirección controles de criterios 0/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Lee Seung-Yeol
Chief Executive Officer (CEO)
n/a
Compensación total
Porcentaje del salario del CEO | n/a |
Permanencia del CEO | no data |
Participación del CEO | n/a |
Permanencia media de la dirección | sin datos |
Promedio de permanencia en la Junta Directiva | sin datos |
Actualizaciones recientes de la dirección
Recent updates
PharmGen Science's (KRX:004720) Shareholders Have More To Worry About Than Only Soft Earnings
Mar 27Is Wooridul Pharmaceutical (KRX:004720) A Risky Investment?
Mar 21Investors Who Bought Wooridul Pharmaceutical (KRX:004720) Shares Five Years Ago Are Now Up 55%
Jan 19Does The Market Have A Low Tolerance For Wooridul Pharmaceutical Limited's (KRX:004720) Mixed Fundamentals?
Dec 21Are Wooridul Pharmaceutical's (KRX:004720) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 25CEO
Lee Seung-Yeol (43 yo)
no data
Permanencia
Seung-Yeol Lee serves as the Chief Executive Officer of PharmGen Science Inc. (formerly known as Wooridul Pharmaceutical Limited). Seung-Yeol Lee serves as the President of Winnova Co., Ltd. Seung-Yeol Lee...